Ipilimumab

Publications : 0
Followers : 0

Ipilimumab

Recombinant monoclonal antibody to CTLA4. Ipilimumab (known as MDX-010 and MDX-101), marketed as Yervoy, is a drug used for the treatment of melanoma, a type of skin cancer. It is a U.S. Food and Drug Administration (FDA) approved human monoclonal antibody, and works by activating the immune system by targeting CTLA-4.
Cytotoxic T lymphocytes (CTLs) can recognize and destroy cancer cells. However, there is also an inhibitory mechanism that interrupts this destruction. Ipilimumab turns off this inhibitory mechanism and allows CTLs to continue to destroy cancer cells.

Like this book? You can publish your book online for free in a few minutes!

Create your own flipbook

View Text Version Likes : 0
Category : All Report

Follow
Upload
0
Embed
Share

Ipilimumab